Jobs / United States / Orakl Oncology
Research Lead, Predictive Oncology
Orakl Oncology · 🇺🇸 Villejuif
Sponsorship verdict
No sponsorship evidence yet
No government record and no wording either way. Not a refusal — ask the recruiter.
- No government sponsor record hereThis employer posted directly and does not match a government sponsor register.
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Why not apply?
No register record and no sponsorship wording in the posting. Worth asking the employer before investing significant time.
SponsorApply flags time-wasters so your applications go where they can land. These come from the posting's own wording — read the original listing to confirm. See better-fit alternatives →
Sponsor Radar — Orakl Oncology
This employer posted directly and does not match a government sponsor register.
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Orakl Oncology →
About the role
About Orakl Oncology At Orakl Oncology, we combine patient-derived tumor models, experimental drug screening and computational modelling to improve oncology drug development. Our research brings together functional treatment-response measurements, molecular profiles and clinical information where available, creating opportunities to investigate how experimental responses translate into patient outcomes. Our platforms are designed to help anticipate clinical trial outcomes, evaluate therapies and identify new therapeutic opportunities. Our mission is simple yet ambitious: to bring more effective treatments to patients who need them and to make drug development smarter, faster, and more personalised. We collaborate with top hospitals, research institutes, and pharmaceutical companies worldwide. Backed by leading investors, we are a fast-growing, mission-driven startup at the intersection of science and technology. About the Role We are looking for a Research Lead - Predictive Oncology, to build and lead a research programme to improve the translational capabilities of Orakl Oncology’s platform, and to provide the scientific backbone of O-Predict, Orakl’s predictive solutions. You will own O-Predict's long-term scientific roadmap, choose the questions we pursue, and lead the work needed to answer them. The opportunity combines access to Orakl's experimental and molecular data, clinical information where available, and the ability to shape future data generation with our experimental and clinical collaborators. This is a hands-on scientific leadership role . You will develop and test methods, mentor contributors, and build a coherent body of research with a recognisable scientific contribution. Publications, presentations and external collaborations will be integral outputs of that programme. You will work closely with the CTO and our Data Science, Computational Biology, experimental, product and engineering colleagues. Your research will establish which predictions are reliable, identify their limitations, and inform how O-Predict can support drug-development decisions. The role is suited to a researcher ready to take ownership of an independent programme within a collaborative company, including an emerging research leader with a strong record of original work. What You'll Do Own O-Predict's long-term research roadmap: define and maintain a 2-year scientific agenda, translated into a prioritised 12-month execution plan. Identify the key uncertainties, research hypotheses, data requirements, dependencies and resources; set milestones and explicit criteria for continuing, redirecting or stopping projects. Review priorities with the CTO as evidence and company needs evolve. Lead R&D execution: take research programmes from question formulation through method development, validation and interpretation. Coordinate agreed contributions across Data Science, Computational Biology and experimental teams, establish project ownership, run scientific reviews, resolve blockers and mentor researchers. Remain hands-on in the analyses and modelling decisions that determine scientific quality. Shape future data generation: identify the experiments, measurements and cohorts that would resolve important scientific uncertainties. Co-design these studies with experimental and clinical colleagues, prioritise them within the agreed research allocation, and use the results to test and revise your hypotheses. Advance O-Predict's predictive capabilities: investigate how drug screening, patient-derived models, molecular and clinical data can improve treatment-response and trial-outcome predictions. Assess extensions to new cohorts, indications and therapeutic settings, specifying the evidence needed before extending claims. Own the validation strategy: defi